Bettina Lundgren is CEO of Danish National Genome Center. Danish National Genome Center was established 1st of May 2019. The centre supports further development of personalised medicine in Denmark with new treatments through the use of knowledge and new technologies. Bettina Lundgren has been CEO of Danish National Genome Center from 1st of September 2019 and leads the further establishment of the centre with a strong focus on patient outcome and the promotion of international and national cooperation within research and across the Danish Health Care system.
Lundgren has contributed as chair, vice chair and member of numerous committees, including several clinical health councils (the Capital Region of Denmark) and chairman of the Genome Center for East Denmark. Her experience also includes chairing implementation of several large regional and national healthcare IT-system and quality initiatives.
She has a strong leadership profile, in-depth knowledge of the Danish healthcare system and extensive clinical experience from a range of clinical departments. Lundgren is a specialist in clinical microbiology and doctor of medical science (D.M.Sc.) from the University of Copenhagen. Prior to her appointment at Danish National Genome Center Lundgren has since 2010 been the centre director of more than 1,600 employees at Diagnostic Center Copenhagen University Hospital (Rigshospitalet). She has also been head of department at Hvidovre Hospital and at one of Denmark’s largest research institutions in health, Statens Serum Institut (SSI). Lundgren’s career spans over 19 years of management experience in the Danish health care system and broad research experience from a number of positions in and outside Denmark, including US National Institutes of Health (NIH), and she has contributed to more than 70 scientific publications.
2019 – present: CEO, National Genome Center
2010 – 2019: Centre director, Diagnostic Centre Copenhagen University Hospital
2000 – 2010: Senior consultant, Hvidovre Hospital, Department of Clinical Microbiology 1999 – 1999: Head of department and consultant – Statens Serum Institut (SSI), Department of Mycobacteriology